Logo image
Utility of a US Food and Drug Administration (FDA) label indication for condoms for anal sex
Journal article   Open access   Peer reviewed

Utility of a US Food and Drug Administration (FDA) label indication for condoms for anal sex

Aaron J. Siegler, Lauren Ahlschlager, Elizabeth M. Rosenthal, Patrick S. Sullivan, Colleen F. Kelley, Eli S. Rosenberg, Travis H. Sanchez, Renee H. Moore, C. Christina Mehta and Michael P. Cecil
Sexual health, v 17(1), pp 91-95
01 Jan 2020
PMID: 31610140
url
https://doi.org/10.1071/SH18152View
Published, Version of Record (VoR) Open

Abstract

Infectious Diseases Life Sciences & Biomedicine Public, Environmental & Occupational Health Science & Technology
Condoms are highly effective for HIV prevention, yet are not currently indicated by the US Food and Drug Administration (FDA) for anal sex. We surveyed a national sample of men who have sex with men to assess whether FDA label indication could affect anticipated condom use, and to determine levels of perceived condom failure for anal sex. We found that 69% of respondents anticipated that a label indication change would increase their likelihood of condom use. Median perceived failure was 15%. We anticipate that these results may aid the FDA in developing standards for a label indication for anal sex.

Metrics

2 Record Views
1 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Infectious Diseases
Public, Environmental & Occupational Health
Logo image